Neutrophils respond rapidly to cerebral ischemia and are thought to contribute to inflammation-mediated injury during stroke. Using myeloid Mcl1 knockout mice as a model of genetic neutrophil deficiency, we investigated the contribution of neutrophils to stroke pathophysiology. Myeloid Mcl1 knockout mice were subjected to transient middle cerebral artery occlusion and infarct size was assessed by MRI after 24 h reperfusion. Immune cell mobilization and infiltration was assessed by flow cytometry. We found that myeloid Mcl1 knockout mice had significantly reduced infarct size when compared to heterozygous and wild type control mice (MyMcl1 ). This was accompanied by a nearly complete absence of neutrophils in the ischemic hemisphere of myeloid Mcl1 knockout mice. Although myeloid Mcl1 knockout mice were protected from cerebral infarction, no significant differences in neurological deficit or the mRNA expression of inflammatory genes (TNFα, IL-1β, and MCP1) were detected. Inhibition of neutrophil chemotaxis using CXCR2 pepducin treatment partially reduced neutrophil mobilization and recruitment to the brain after stroke, but did not reduce infarct size 24 h after transient MCA occlusion. These data confirm that neutrophils have an important role in infarct development during stroke pathophysiology, and suggest that complete deficiency, but not partial inhibition, is necessary to prevent neutrophil-mediated injury during stroke.
A B S T R A C T
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Introduction
Immune cells are critical components of stroke pathophysiology where they respond rapidly to cerebral ischemia and have profound effects on stroke outcome. At the onset of ischemia, both protective and harmful inflammatory signaling molecules are released, and resident and blood-borne immune cells are rapidly mobilized and recruited to the site of injury. Innate immune cells comprised of microglia, neutrophils, and monocytes/macrophages are recruited first, followed by an adaptive immune response comprised of lymphocytes and antigen presenting cells. Targeting the inflammatory response has the potential to be an important therapeutic strategy; however, there has been poor clinical translation of successful preclinical therapies likely due to our incomplete understanding of the critical immune cell phenotypes and their complex responses to cerebral ischemia.
Neutrophils rapidly infiltrate the ischemic brain and are thought to have a proinflammatory, detrimental effect during stroke pathogenesis (Jickling et al., 2015) . Intravital microscopy imaging has shown that neutrophils can infiltrate the brain within minutes after injury, and although neutrophil numbers are greatest 24-48 h after stroke, it is likely that they affect stroke pathophysiology much earlier (Roth et al., 2014) . Studies have attempted to identify the contribution of neutrophils and other circulating cells during stroke by targeting cellular adhesion molecules and integrins. These studies have shown that inhibition of immune cell recruitment or inhibition of proinflammatory mediators can significantly reduce infarct size and protect against stroke (Iadecola and Anrather, 2011) . Inhibition of immune cell recruitment by genetic ablation or antibody neutralization of the adhesion molecules ICAM-1, P-Selectin, and E-Selectin is protective in animal models of ischemic stroke (Bowes et al., 1995; Connolly et al., 1997; Connolly et al., 1996; Goussev et al., 1998; Huang et al., 2000; Suzuki et al., 1999; Zhang et al., 1995; Zhang et al., 1994) . Similarly, genetic deficiency in the leukocyte-specific integrin CD18 and Mac-1 (CD11b/CD18), which binds to ICAM-1, also decrease infarct volume during stroke (Prestigiacomo et al., 1999; Soriano et al., 1999) . Blocking leukocyte chemotaxis through inhibition of inflammatory chemokines like Mcp1 and Cx3cl1 and their cognate receptors CCR2 and CX3CR1 has also been shown to be protective during stroke (Denes et al., 2008; Dimitrijevic et al., 2007; Hughes et al., 2002; Kumai et al., 2004; Soriano et al., 2002) . In many of these studies, neuroprotection correlates with reduced neutrophil infiltration, but these strategies for immune cell inhibition are non-specific and can also inhibit the recruitment of other circulating leukocytes. Although anti-neutrophil serum can be protective during models of stroke (Connolly et al., 1996; Cuartero et al., 2013; Murikinati et al., 2010) , many of these antibodies can result in cross-reactivity and non-specificity leading to question whether the effect is the result of multiple cell types. There is still much controversy regarding neutrophils and whether they have a pathogenic (or possibly beneficial) role during stroke and whether their presence is merely correlative with injury (reviewed in (Emerich et al., 2002) ). More recently, genetic models of immune cell deficiency have been useful in delineating the roles of myeloid cells, T cells and B cells during stroke (Gliem et al., 2012; Kleinschnitz et al., 2010; Ren et al., 2011; Shichita et al., 2009; Yilmaz et al., 2006) .
Mcl1 is a member of the antiapoptotic Bcl-2 family, which regulates apoptosis in immune cells and it is essential for neutrophil survival (Kozopas et al., 1993; Marsden and Strasser, 2003) . It has been previously reported that genetic ablation of Mcl1 in myeloid cells results in neutrophil deficiency while not significantly affecting macrophage or other myeloid cell survival (Dzhagalov et al., 2007; Steimer et al., 2009 ). In the current study, we investigated the effect that genetic neutrophil deficiency had during cerebral ischemia. We hypothesized that mice lacking neutrophils would have decreased inflammation and would be protected in a model of ischemic stroke.
Methods

Animals and treatments
All animal procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals (8th Edition) and were approved by the Institutional Animal Care and Use Committee of the University of Michigan. All mice were maintained on standard laboratory chow (5L0D, LabDiet) and water ad libitum. Myeloid Mcl1 knockout mice were on a C57BL/6J background and were generated by crossing floxed ) were used as controls. For CXCR2-pepducin experiments, wild type C57BL6/J male mice 8-10 wk. old and weighing 22-25 g were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice received a previously determined dose (2.5 mg/kg) of CXCR2-pepducin (RTLFKAHMGQKHR, palmitoyl N-terminal, amidation C-terminal) or control peptide (TRFLAKMHQGHKR, palmitoyl N-terminal, amidation C-terminal) in sterile saline 3 h before MCAo via intravenous injection (Jamieson et al., 2012; Kaneider et al., 2005) . Mice received an additional subcutaneous injection of pepducin 9 h after stroke.
Middle cerebral artery occlusion
Mice were anesthetized with isoflurane (5% induction, 1.5% maintenance) and core body temperature was maintained at 37°C using a temperature controller with heating pad and rectal probe. An 8 mm midline incision was made in the neck and the submaxillary glands were dissected to expose the right common, external and internal carotid arteries. The external carotid artery was ligated and divided, and a 10 mm long 6-0 silicon rubber-coated nylon monofilament (#602156, Doccol Corporation, CA) was inserted into the external carotid stump and advanced into the internal carotid artery. Regional cerebral blood flow was monitored by laser Doppler flowmetry (Transonic BLF22) before and during monofilament insertion to verify MCA occlusion. Occlusion was defined as a reduction in cerebral tissue perfusion to a level < 20% of baseline. After 90 min, the filament was removed and animals were allowed to recover.
Measurement of infarct volume
Infarcts were assessed by magnetic resonance imaging (MRI) after 24 h reperfusion. Mice were anesthetized with 2% isoflurane/air mixture throughout MRI examination. Mice lay prone, head first in a 7.0T Varian Unity Inova MR scanner (183-mm horizontal bore; Varian, Palo Alto, CA), with the body temperature maintained at 37°C by forced heated air. A double-tuned volume radiofrequency coil was used to scan the head region of the mice. Axial T2-weighted images were acquired through the use of a fast spin-echo sequence with the following parameters: repetition time/effective echo time, 4000/60 ms; echo spacing, 15 ms; number of echoes, 8; field of view, 20 × 20 mm; matrix, 256 × 128; slice thickness, 0.5 mm; number of slices, 25; and number of scans, 1 (total scan time = 2.5 min). The infarct volumes were analyzed using NIH ImageJ software (version 1.43) by a blinded observer, and infarct volumes were corrected to account for brain swelling.
The following equation was used to calculate the corrected T2-lesion volumes: TV − ((CV + (IV − LV) × ((TV / 2) / CV)); TV indicates total volume in both hemispheres; CV, contralateral volume; IV, ipsilateral volume; and LV, lesion volume.
Evaluation of neurological deficit
Neurological deficits were determined 24 h after MCA occlusion. Neurological scores were assigned using the following criteria: 0, no deficit; 1, forelimb flexion and torso turning to the contralateral side when held by tail; 2, circling to contralateral side; 3, unable to bear weight on contralateral side; and 4, no spontaneous locomotor activity.
Flow cytometry
Cerebral hemispheres were dissected and minced into small pieces with a razor blade in RMPI containing 5% FBS, and the homogenate was passed through a 40 μm cell strainer. Leukocytes were purified by density gradient centrifugation using a 30% percoll solution and washed twice with PBS. Peripheral whole blood was collected, RBCs were lysed by 10 s hypotonic shock using distilled water, and remaining leukocytes were washed with PBS. Cells were incubated in Fc Block for 10 min and then stained on ice for 1 h with the following antibodies: PE anti-mouse CD45 (BioLegend, cat # 103106), APC anti-mouse CD11b (BioLegend, cat # 101211), FITC anti-mouse Ly6G (BioLegend, cat # 127606), Pacific Blue anti-mouse Ly6C (BioLegend, cat # 128014). Stained cells were washed twice in PBS and fixed in 0.1% paraformaldehyde before analysis. Flow cytometric analysis was performed on a FACSCanto II Flow Cytometer (BD Biosciences) equipped with three lasers (405-nm violet laser, 488-nm blue laser, and 640-nm red laser) and analyzed with FlowJo software (Treestar). Unstained and isotype controls were used for flow analysis.
mRNA expression analysis
Relative mRNA expression was determined using quantitative reverse transcription-polymerase chain reaction (qPCR). Total RNA was isolated from whole cerebral hemispheres using TRIzol reagent and purified using an RNeasy Mini Kit (Qiagen) with an on-column DNase digestion. RNA (1 μg) was reverse transcribed to cDNA with an Applied Biosystems kit and qPCR was performed using a 7900HT fast real-time PCR system (Applied Biosystems). The relative mRNA expression was quantified using the comparative method and normalized to the ribosomal housekeeping gene L32.
Statistics
A Shapiro-Wilk normality test was used to determine if data were normally distributed. For normally distributed data with equal variance, statistical comparison of mean values between groups was performed with the Student t-test or by a two-way ANOVA with a Bonferroni post-test, and values are presented as mean ± SEM. All statistical analysis of data was performed in GraphPad Prism (version 6; GraphPad Software, Inc.). P < 0.05 was considered significant.
Results
Myeloid Mcl1 knockout mice are protected during cerebral ischemiareperfusion
In order to define the contribution of neutrophils during stroke, we used myeloid Mcl1 knockout mice (MyMcl1 −/− ) that have a neutrophil deficiency. Consistent with previous reports (2001 ; Dzhagalov et al., 2007; Steimer et al., 2009) , homozygous MyMcl1 −/− mice had a nearly complete loss of neutrophils from blood when compared to controls where as heterozygous MyMcl1 +/− mice were not dramatically affected ( Fig. 1) . In contrast, circulating monocytes were comparatively normal in MyMcl1 −/− mice.
To test whether neutrophil deficiency affected stroke pathophysiology, MyMcl1
−/− and control mice were subjected to a 90 min transient middle cerebral artery occlusion (tMCAo) followed by 24 h of reperfusion. After 24 h reperfusion, infarcts assessed by T2-weighted MRI were significantly decreased in the MyMcl1 −/− group when compared to both wild type (MyMcl1
) and heterozygous (MyMcl1 +/− ) controls (Fig. 2A) . Quantification of infarct sizes using ImageJ software revealed a significant decrease in infarct percent in the ipsilateral hemisphere (Fig. 2B ) with a 29% reduction in the infarct volume ( Fig. 2C) detected between wild type and heterozygous mice. Neurological deficit was assessed 24 h after stroke, but there were no significant differences in in MyMcl1 −/− mice when compared to controls (Fig. 2D ).
Myeloid Mcl1 knockout prevents neutrophil mobilization and recruitment after stroke without altering inflammatory mRNA gene expression
We next determined whether myeloid Mcl1 knockout impaired neutrophil survival, mobilization, and recruitment during ischemic injury. Similar to naïve, uninjured mice, MyMcl1 −/− mice had severe neutrophil deficiency in the blood 24 h after stroke (Fig. 3) . In addition, MyMcl1 −/− mice also showed a dramatic reduction in the percentage of neutrophils in the ipsilateral hemisphere when compared to MyMcl1 +/− controls ( Fig. 3) −/− : 4.9 ± 0.8).
Since neutrophils are major components of the inflammatory response and can contribute to ischemic injury through secretion of inflammatory cytokines, we assessed whether MyMcl1 −/− mice had altered inflammatory signaling in the brain. The mRNA expression of proinflammatory cytokines 24 h after transient MCA occlusion revealed a strong induction of proinflammatory genes in the ischemic, ipsilateral hemisphere when compared to the contralateral hemisphere (Fig. 4) . Surprisingly, despite the reduced infarct size in MyMcl1 −/− , we did not detect any significant differences in the expression of the inflammatory genes TNFα, IL1β and MCP1 in the ischemic hemisphere when compared to controls (Fig. 4) . This is indicates that inflammatory mRNA gene expression did not correlate with neutrophil infiltration or infarct size, and it suggests that neutrophils affect stroke pathophysiology and infarct development through a different mechanism.
Inhibition of neutrophil chemotaxis with CXCR2 pepducin does not protect against stroke
We next sought to determine if a novel CXCR2 pepducin could prevent neutrophil chemotaxis and prevent neutrophil-mediated stroke damage in mice. Pepducins are cell-penetrating lipopeptides that can be designed to specifically target and inhibit receptor signaling. CXCR2 is highly expressed by neutrophils, and CXCR2 pepducin selectively inhibits neutrophil recruitment in other inflammatory disease models (Jamieson et al., 2012; Kaneider et al., 2005) . Mice were injected intravenously with CXCR2 pepducin 3 h before tMCAo and then again 12 h later and assessed neutrophil mobilization and recruitment by flow cytometry. Compared to nontargeting control peptide treatment, CXCR2 pepducin decreased the number of circulating neutrophils after tMCAo (Fig. 5) . Similarly, flow cytometric analysis of brain also revealed a reduction in the number of Ly6G + neutrophils in the ipsilateral hemisphere after stroke. To determine if this decrease in neutrophils affected stroke infarct development, we assessed infarct size by MRI after 24 h reperfusion. In contrast to genetic neutrophil deficiency, CXCR2 pepducin did not reduce infarct size after tMCAo. CXCR2 pepducin treated mice did not show any significant reductions in infarct size or neurological function when compared to control peptide treated mice (Fig. 6 ).
Discussion
Neutrophils have long been thought to be major contributors to inflammation-mediated injury during stroke, and many studies have and knockout (MyMcl1 −/− ) mice. CD45 hi leukocytes were gated on monocyte and neutrophil-specific markers, Ly6C and Ly6G, as shown. Frieler et al. Experimental Neurology 298 (2017) 104-111 used antibodies to neutralize neutrophils in order to define their role during stroke (Connolly et al., 1996; Cuartero et al., 2013; Murikinati et al., 2010) . In the present study, we used a highly selective genetic model with neutrophil deficiency to delineate the contribution that neutrophils have in cerebral infarct formation and inflammationmediated injury. Here we have shown that neutrophil deficiency in myeloid Mcl1 knockout mice reduces infarct size after cerebral ischemia-reperfusion injury. We found that myeloid Mcl1 knockout mice were nearly completely devoid of neutrophils in the ischemic hemisphere as well as in the circulation. hi leukocytes were gated on the myeloid and neutrophil-specific markers, CD11b and Ly6G, as shown.
R.A. Frieler et al. Experimental Neurology 298 (2017) 104-111
Interestingly, we did not detect any differences in the mRNA expression of proinflammatory cytokines TNFα, IL1β and MCP1 indicating that stroke protection did not correlate with inflammatory mRNA gene expression. This is suggestive of an alternate mechanism by which neutrophils contribute to injury and affect infarct formation during stroke. Neutrophils are major producers of reactive oxygen species, and oxidative damage is thought to be a major mechanism of injury by immune cells during ischemia-reperfusion injury. Therefore, it is possible that neutrophil-derived reactive oxygen species are the major pathological mechanism by which neutrophils contribute to stroke damage. In support of this, one study using antibody depletion of neutrophils found protection in a transient, but not permanent occlusive stroke model (Prestigiacomo et al., 1999) . Since reactive oxygen species are a thought to be a critical mechanism of reperfusion injury, this would support this hypothesis.
Consistent with the literature, we did not detect any differences in the survival of other immune cell populations in MyMcl1 −/− mice. It is possible that while not affecting apoptosis or survival in these other myeloid cell populations, Mcl1 may have significant effects on cell phenotype during cerebral injury. Although Mcl1 knockout does not affect macrophage response to TLR-induced cytokine production (Dzhagalov et al., 2007) , it has been shown to be important in macrophage regulation during bacterial clearance (Marriott et al., 2005) . Therefore, we cannot rule out the possibility that other myeloid cell populations may be involved. The Mrp8-Cre or Ly6G-Cre are more neutrophil-specific and might provide further support for a specific role for neutrophils (Abram et al., 2014) . Despite a wide body of neutrophil research in stroke over the past several decades, the role of neutrophils in stroke pathogenesis remains controversial. Although numerous studies have found that neutrophil depletion strategies are protective in experimental stroke, there are conflicting results among different studies making it difficult to draw conclusions about the role of neutrophils. For example, there have been several studies that did not detect the presence of neutrophils in the infarct region prior to infarct formation indicating that neutrophil presence may be correlative with damage (Hayward et al., 1996; Lehrmann et al., 1997) and many other studies that have shown beneficial effects failed to assess temporal changes in both infarct and neutrophil infiltration (Emerich et al., 2002) . It is also concerning that no studies have shown any type of dose effect with neutrophil depletion methods. Comparison of studies that demonstrate an effect or lack of effect is further complicated by differences in stroke models (permanent v. transient ischemia; intraluminal filament v. ligation v. thrombus) and animal model. In our experiments, we confirmed the absence of neutrophils before and after stroke suggesting a pathological role for neutrophils in our cerebral ischemia-reperfusion stroke model. Although Mcl1 deficiency does not affect the development of other myeloid cell types, it is possible that it might have other unknown roles that could be responsible for the neuroprotection observed in MyMcl1 −/− mice.
More recently, the existence of multiple neutrophil phenotypes similar to the spectrum of macrophage activation states has been reported. Although data on these neutrophil phenotypes and their functional roles are unknown, it has been shown that neutrophils can also express the alternatively activated macrophage markers CD206 and Ym1 (Certo et al., 2015; Cuartero et al., 2013) . It has been proposed that these CD206 and Ym1-expressing neutrophils may have beneficial effects on resolution of inflammation similar to alternatively activated macrophages. Our data suggest that neutrophils have detrimental effects during early infarct formation since neutrophil deficiency significantly decreased infarct size 24 h after ischemia-reperfusion injury. However, we did not determine the effect of neutrophil deficiency on infarct size and functional deficit at later time points, and so it is possible that neutrophils contribute significantly to the oxidative damage during early stages of ischemia-reperfusion injury, but may also have important roles during later stages of healing.
In this study, we were unable to induce neuroprotection with intravenous injection of CXCR2 pepducin at a dose similar to what has been reported in the literature to significantly prevent neutrophil mobilization and chemotaxis. Although we did reduce neutrophil mobilization and recruitment to the brain, we only saw an approximate 50% reduction in the total number of neutrophils perhaps suggesting that small numbers of neutrophils can have full effects.
Neutrophils can respond to a various cytokines and chemokines, and there is a wide array of chemotactic signaling molecules released during B. C. Fig. 6 . Effect of CXCR2 pepducin treatment on infarct size and neurological deficit after stroke. Wild type mice on a C57BL/6 J background received intravenous injection of CXCR2 pepducin (2.5 mg/kg) 3 h before and 9 h after stroke. (A) Representative MRI sections from untreated, control peptide and CXCR2 pepducin treated mice 24 h after transient (90-min) MCA occlusion. (B) Infarct volume in the ipsilateral hemisphere and (C) neurological deficit in mice 24 h after stroke. Data are expressed as mean ± SEM. n = 6-7 per group. R.A. Frieler et al. Experimental Neurology 298 (2017) 104-111 stroke. Although previous studies have shown CXCR2 pepducin can effectively suppress neutrophil chemotaxis, the milieu of chemotactic molecules during stroke is likely to be dramatically different and may be more profound. A previous report using the CXCR2 antagonist SB225002 found that pharmacological inhibition was only protective in hyperlipidemic mice (Herz et al., 2015) . Our data suggest that a greater decrease in neutrophil infiltration is necessary to prevent the detrimental effects of neutrophils, and complete inhibition of neutrophil chemotaxis may not be achievable through inhibition of a single chemokine signaling pathway in our model.
Conclusions
In this study, we have shown using a highly selective genetic model of neutrophil deficiency, that neutrophils have an important role in infarct development during stroke pathophysiology. We found that neutrophil deficiency decreased infarct size during cerebral ischemiareperfusion injury independent of inflammatory mRNA gene expression. We further demonstrated that incomplete inhibition of neutrophil chemotaxis with CXCR2 pepducin is not sufficient to reduce the detrimental effects of neutrophils during stroke, indicating that even small neutrophil populations can have substantial effects.
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